SATURDAY, JULY 21, 2018

Immunovaccine

1344 Summer St
Halifax, NS B3H 0A8

Immunovaccine News

Immunovaccine launches clinical trial for DPX-RSV vaccine

Immunovaccine, Inc., a Nova Scotia-based clinical stage vaccine and immunotherapy company, said Tuesday the first healthy volunteer has enrolled in the Phase 1 clinical study of its respiratory syncytial virus (RSV) vaccine. Read More »